Month: July 2021

Mid-cap stocks are often overlooked. However, there are terrific dividend stocks in the mid-cap group that we think are worthy of consideration for income investors. In the world of investing, many investors focus on the biggest stocks in the market – so-called large caps – for their stability and predictability. This makes large-cap stocks generally
0 Comments
Increased concern over inflation and valuations have brought choppiness back to equity markets. As the stock market recovers from a volatile month of trading, investors have turned their attention towards more defensive stocks. For many market participants, dividend shares seem to be the most reasonable plays. High-yield dividend stocks are prized among income investors, as
0 Comments
Most investors who want to gain exposure to the financial sector focus exclusively on the well-known U.S. bank stocks, such as Wells Fargo (NYSE:WFC) and Bank of America (NYSE:BAC), and that goes for income investors as well. However, some Canadian bank stocks have much lower valuations and also have higher dividend yields than their domestic counterparts.
0 Comments
Global oil consumption is recovering from the pandemic, which has driven oil prices higher, with Brent crude rising over $70 per barrel. This rally will greatly benefit oil producers, especially oil stocks from the global majors that rely more heavily on the price of oil. In addition, several top oil stocks pay high dividend yields
0 Comments
Exxon Mobil (NYSE:XOM) stock looks like it is significantly undervalued at today’s price. On July 8, it closed at $60.14, but XOM stock has a very attractive valuation. For example, it sports a very healthy 5.76% dividend yield and trades for just 16 times this year’s forecast earnings. Source: Jonathan Weiss / Shutterstock.com My valuation
0 Comments
In most cases, taking longshot bets in the market don’t pan out. However, for those brave contrarians that bought publicly traded securities during the initial onslaught of the novel coronavirus pandemic, they managed to accrue incredible profitability. Many onlookers quickly followed with their own money, making the case for buying super-safe dividend stocks less appealing
0 Comments
Other than a massive trading spike in Feb. 2020 to $24.90, Vaxart (NASDAQ:VXRT) has gone nowhere. A mid-June upgrade from Piper Sandler to an “overweight” rating temporarily lifted VXRT stock, but its price remains low. Source: Photo courtesy of Vaxart, Inc. When vaccines are making headlines every day, why are Vaxart shares underperforming? And why
0 Comments